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ABSTRACT  31 
Objective: The aim of this study was to analyze, in recreational marathon runners, the intake of spe-32 
cific macronutrients and minerals that could influence cardiovascular health. 33 
Methods: 37 males were grouped in two groups according to their 50% percentile race time (3.39 h), 34 
dividing into fast (G1: 3.18 ± 0.18 h) and slow runners (G2: 3.84 ± 0.42 h). Anthropometric parameters, 35 
macronutrients and mineral records were collected before the race. Minerals (Na+, K+ and Mg2+), lipid 36 
profile (triglycerides, LDL, HDL and cholesterol), muscle damage (creatine kinase), inflammation (C-37 
reactive protein), and cardiovascular health (high-sensitive troponin-T, ST2 and N-terminal pro-B-38 
type natriuretic peptide) were analyzed in blood 24 h before, immediately after, and 48 h post-race.  39 
Results: Weight (G1: 74.70 ± 7.76 kg, G2: 79.58 ± 6.72 kg; p < 0.05) and body mass index (G1: 23.01 40 
± 1.81 kg/m2, G2: 25.30 ± 2.02 kg/m2; p < 0.01) were significantly different between the groups. 41 
Moreover, G1 consumed significantly (p < 0.01) more mono- and poly-unsaturated fatty acids than 42 
G2, and presented significantly higher iron, potassium, and magnesium intake. Regarding blood lipid 43 
profile, G2 presented significantly higher triglyceride values and lower levels of high-density lipopro-44 
tein (p < 0.01). The Hs-TnT marker of cardiac myocyte stress/injury was significantly higher (p < 45 
0.05) in G2 reaching values above 250 ng/L, and 81% of the runners (30 from 37) presented higher 46 
post-race values. 47 
Conclusions: Marathon runners consuming adequate amounts of unsaturated fat, iron, potassium and 48 
magnesium, performed better and presented better cardiovascular health. 49 
Keywords: macronutrients; minerals; marathoners; performance; cardiovascular health. 50 




Recreational marathons have become very popular in recent years. When performed properly, aerobic 53 
exercises are an optimal way to improve cardiovascular health, reducing morbidity and mortality [1]. 54 
Similarly, it has been shown that low performance can culminate in early fatigue, where nutrition plays 55 
a very important role [2,3]. In this sense, what we eat influences our body´s capabilities to adapt to 56 
training and post-exercise recovery [4,5]. Several sports medicine- and nutrition-related organizations 57 
recommend specific amounts of energy, macro- and micro-nutrients for sustained physical activity 58 
events in order to maintain body weight, replenish glycogen stores, and provide sufficient proteins to 59 
build and repair working tissues [2,6,7]. Optimal carbohydrates are needed before, during, and after 60 
intense and prolonged exercise, both during training and competition, for proper performance [7]. 61 
Also, fat is of particular interest among macronutrients for endurance athletes, as it provides energy, 62 
fat-soluble vitamins, and essential fatty acids, which are associated with a lower risk of cardiovascular 63 
disease and mortality [8,9]. 64 
When there is an increase in the duration and intensity of an endurance exercise like a marathon, there 65 
is at the same time an inter-individual response that depends on the level of physical training, resting 66 
conditions, energy disposal, and psychological status, among other parameters [10,11]. In addition, 67 
prolonged strenuous endurance exercise can also alter other physiological processes such as fluid im-68 
balance and electrolyte levels [12]. Proper nutrition can help mitigate the majority of these problems 69 
[13].  70 
Recreational runners, which represent the majority of endurance practitioners, generally focus on mac-71 
ronutrient intakes, disregarding the role of micronutrients that are mainly lost through sweat produc-72 
tion [14]. Our hypothesis is that improper nutrition before an endurance event such as a marathon can 73 
affect the runner’s performance and cardiovascular health. Therefore, an adequate diet should be de-74 
signed considering several components: i.e., water with electrolytes, high vs. low glycemic index car-75 
bohydrates, saturated vs. unsaturated fat, animal vs. plant-based protein as well as the timing of nutri-76 
ent intake. 77 
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The aim of this research was to analyze in recreational marathon runners the diet effect (content of 78 
macronutrients and minerals such as Na+, K+ and Mg2+) over the race performance and the cardiovas-79 
cular health. 80 
 81 
MATERIALS AND METHODS 82 
Participants 83 
Thirty-seven male runners participating in the 2016 Barcelona Marathon were voluntarily recruited 84 
through the event's organizing committee. The exclusion criteria included participants under 18 and 85 
over 50 years of age, and suffering from any pathology or injury. Ethics approval was obtained from 86 
the “Consejo Catalán del Deporte” (Ref: 0099S/2046/2013) according to principles of Helsinki Dec-87 
laration for experiments with human beings. All participants signed an informed consent. 88 
Data collection 89 
All participants completed a questionnaire including the following items: demographic and health data, 90 
height, weight, and training parameters, such as hours/week, intensities, type of exercise, locations 91 
selected to exercise, racing records, and main classifications in key challenges (data not shown). Train-92 
ing intensities were established according to race rhythm, based on time taken to run 1 km at maximal 93 
intensity. Intensities were adapted during training sessions accordingly (light intensity was performed 94 
as warm-up and moderate for recovery periods, and intensive intensities were planned for marathon 95 
finishing objectives). 96 
The participants were weighed two hours before the race and immediately afterwards, using the same 97 
scale (Jata 565, Barcelona, Spain). 98 
Participants were monitored using a 3-day dietary questionnaire. Individuals were instructed regarding 99 
serving sizes, supplements, beverages, food preparation and other variables that could influence esti-100 
mation of diet composition, which was analyzed using the software DIAL [15].  101 
During the race, the participants were provided with guidelines to maintain adequate levels of hydra-102 
tion. The first liquid intake was programmed at 60 min of the race: 400 ml for lighter/slower runners 103 
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and 800 ml for heavier/faster runners, drinking 100-150 ml every 15-20 min. Commercialized bever-104 
ages were provided to participants with an average of 480 mg/L for Na+, 85 mg/L for K+ and 45 mg/L 105 
for Mg2+. 106 
Blood analysis 107 
Fasting blood samples (3 x 10 ml) were obtained from the antecubital vein in EDTA vacutainers 24h 108 
before the race, immediately after the race, and 48h afterwards. Blood samples were centrifuged at 109 
3000 rpm at 4ºC for 10 min in a bench centrifuge. Supernatant (plasma) was aliquoted and stored on 110 
dry ice until all samples were frozen at -80ºC in sealed Eppendorf tubes to avoid evaporation. 111 
Serum cholesterol, low-density (LDL) and high-density (HDL) lipoproteins, triglycerides, electrolytes, 112 
creatine-kinase (CK) and C-reactive protein (CRP) were determined using the AU-5800 Chemistry 113 
Analyzer (Beckman Coulter). 114 
Hs-TnT Assay 115 
Troponin levels were measured by electrochemiluminescence immunoassay using an Hs-TnT assay 116 
on a Modular Analytics E 170 (Roche Diagnostics). The Hs-TnT assay had an analytic range from 3 117 
to 10,000 ng/L. At the 99th percentile value of 13 ng/L, the coefficient of variation was 9%. The 118 
analytic performance of this assay has been validated and complies with the recommendations of the 119 
Task Force for use in the diagnosis of myocardial necrosis. The assays were run with reagents from 120 
lot 157123, not affected by the analytical issues emerged with Roche Hs-TnT assays. 121 
ST2 Assay 122 
ST2 was measured from plasma samples using a high-sensitivity sandwich monoclonal immunoassay 123 
(Presage® ST2 assay, Critical Diagnostics, San Diego, CA, USA). The antibodies used in the Presage 124 
assay were generated from recombinant protein based on the human cDNA clone for the complete 125 
soluble ST2 sequence. The ST2 assay had a within-run coefficient of <2.5% and total coefficient of 126 
variation of 4%. 127 
NT-proBNP Assay 128 
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NT-proBNP levels were determined using an immuno-electrochemiluminescence assay on a Modular 129 
Analytics E 170 (Roche Diagnostics). This assay has <0.001% cross-reactivity with bioactive BNP, 130 
and in the constituent studies in this report, the assay had inter-run coefficients of variation ranging 131 
from 0.9% to 5.5%. 132 
CRP Assay 133 
CRP concentration was measured using a particle-enhanced turbidimetric immunoassay technique 134 
(CRPHS, Roche Diagnostics, ref. 04628918 190) on an automatic analyzer, Cobas 6000 (Roche Di-135 
agnostics, Switzerland). The method was standardized against BCR470/CRM470 reference material 136 
from the IRMM. The linearity of the method was 0.15-20.0 mg/L; the detection limit was 0.15 mg/L, 137 
the functional sensitivity was 0.3mg/L; and the interserial coefficient of variation was <8.4%. 138 
CK Assay 139 
CK was measured using the AU-5800 Chemistry Analyzer (Beckman Coulter, ref. OSR6179 4). The 140 
method was standardized against controls ODC0003 and ODC0004 or other control materials with 141 
quantified values using this Beckman Coulter system. The reference values in males was ≤ 171 U/L 142 
(2,85 μkat/L) and the interserial coefficient of variation was <4.55%. 143 
Statistical analysis 144 
For the present study, thirty-seven runners were divided into two groups (G1 and G2) according to the 145 
50th percentile of race time (3.39 h). G1 corresponds to the fastest runners according to the values 146 
under the 50th percentile (n=19, 3.18 ± 0.18 h) while G2 corresponds to the slowest runners over the 147 
50th percentile (n=18, 3.84 ± 0.42 h). The race time of each participant was taken from the official race 148 
organization.  149 
The variables sample size [16] was estimated according to the anthropometric of 14 runners (7 by 150 
group), nutrition of 21 runners (10 by group), circulating blood biomarkers of 35 runners (18 by group), 151 
circulating blood electrolytes of 31 runners (15 by group) and blood lipid profile of 39 runners (20 by 152 
group) to have a power (β =0.80) to detect an effect size of 0.996 with a 0.05 significance level using 153 
MedCalc statistical software version 19.0.3 (MedCalc Software bvba, Ostend, Belgium). 154 
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Data was collected 24h before-race, immediately post-race and 48h post-race. The normality of distri-155 
bution of the variables was checked by the Shapiro-Wilk test and homogeneity of variances by 156 
Levene's test. 157 
Repeated measures one-way Anova test was used to determine the effect of the marathon on variables 158 
measured 24h before-race, immediately post-race and 48h post-race. The Kruskal-Wallis test was used 159 
for repeated measures of data non-normally distributed.  160 
In addition, samples were separated in two groups according to their 50% percentile race time (3.39 161 
h), dividing into fast (G1: 3.18 ± 0.18 h) and slow runners (G2: 3.84 ± 0.42 h). Mann Whitney’s U test 162 
or Student’s t-test was applied to analyze non-parametric and parametric variables respectively. 163 
The variables normally distributed are shown as mean ± SD while that non-normally distributed data 164 
are shown as median and interquartile range (IQR). The level of statistical significance was set at P < 165 
0.05. The statistical software IBM® SPSS® version 24.0 (Armonk, NY: IBM Corp, USA) was used for 166 
data analysis. 167 
 168 
RESULTS 169 
Anthropometric, training characteristics and race time 170 
Anthropometric and training characteristics are summarized in Table 1. Significant differences be-171 
tween groups with respect to weight (p < 0.05) and body mass index (p < 0.01) were observed. The 172 
slower runners were significantly heavier than the faster runners, with similar results observed when 173 
considering BMI, although both groups were within the healthy range (BMI = 20-25). In addition, G2 174 
reported less training hours per week compared to G1, and also less light, moderate, and intensive 175 
training hours per week compared to G1, although in all cases the differences were not significant.  176 
Dietary intakes of participants 177 
The diet analysis recorded from the 3 day-questionnaires is shown in Table 2. The values indicate that 178 
all runners participating in this study consumed lower levels of carbohydrates than those recommended 179 
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for endurance athletes (5-10 g/kg of body weight) [17]. In addition, protein intake in G1 was correct 180 
regarding recommendations for endurance runners (1.2-1.4 g/kg of body weight), but was significantly 181 
lower in the G2 group (p < 0.01). Finally, fat intakes were in the recommended levels for endurance 182 
athletes (20-35% kJ of daily diet) in both groups, although G2 consumed significantly less fat than G1 183 
(p < 0.01). Regarding total energy consumption, this was significantly lower in G2 (p < 0.01). How-184 
ever, the participants in this study seemed to consume approximately 25% less energy than recom-185 
mended. Energy requirements for men who are slightly-moderately active and between 19-50 years of 186 
age is established as 12139.4 kJ/day (2900 kcal/day) [13]. 187 
Altogether, G1 presented significantly higher fat intake than G2 (p < 0.01) but presented a lower BMI. 188 
Therefore, the type of fat consumed by the participants was assessed. Runners in G1 consumed signif-189 
icantly higher amounts of mono- and poly-unsaturated fatty acids compared to G2 (p < 0.01), whereas 190 
the amount of saturated fatty acids was similar in both groups. Finally, no significant differences were 191 
observed in cholesterol and water intakes, although fiber intake was significantly higher in G1 (p < 192 
0.01). 193 
According to mineral intake, G1 met the recommended requirements for sodium, potassium, iron and 194 
magnesium (1500, 3100, 9 and 350 mg/day respectively), whereas G2 did not reach the recommended 195 
amounts for potassium and magnesium, with significant differences compared to G1 (p < 0.01). Cal-196 
cium was also under the recommended requirements (900 mg/day) in both groups, and iron intake was 197 
significantly higher in G1 (p < 0.05). 198 
Blood markers of muscle damage, inflammation and cardiovascular health 199 
The total serum biomarkers associated to muscle damage, inflammation and cardiovascular health are 200 
shown in Table 3.  Initial levels of circulating CK in G1 and G2 were significantly higher in G2 before-201 
race (p < 0.05) and post-race (p < 0.01), reaching the highest values 48h post-race (nearly 2400 U/L). 202 
Inflammatory C-reactive protein biomarker in G2 was significantly higher (p < 0.01) post-race and 203 
48h post-race, also reaching the highest levels between groups (24 mg/dL).  204 
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Regarding cardiovascular parameters-- Hs-TnT, NT-proBNP and ST2, no significant differences were 205 
observed in two of the three cardiovascular biomarkers analyzed between groups, but there were values 206 
post-race that were over the cut-off point. The ST2 marker of extracellular matrix remodeling, fibrosis, 207 
inflammation, and myocardial strain has a cut-off  35 ng/mL, and 78% of the 37 runners presented 208 
higher post-race values. The NT-proBNP marker of myocardial strain has a cut-off  125 ng/L, and 209 
27% of the runners (10 of 37) presented higher post-race values. The Hs-TnT marker of myocyte 210 
stress/injury has a cut-off  14 ng/L, and 81% of the runners (30 from 37) presented higher posts-race 211 
values. In addition, Hs-TnT value post-race was significantly higher (p < 0.05) in G2, reaching values 212 
above 250 ng/L. 213 
Blood minerals and lipid profile  214 
Total serum micronutrients such as Na+, K+ and Mg2+, and lipid profile are shown in Table 4. No 215 
significant differences were observed in circulating electrolytes between groups. Triglycerides were 216 
significantly higher in G2 before (p < 0.05) and 48h post-race (p < 0.01), and HDL levels were signif-217 
icantly higher in G1 compared to G2 before, post-race and 48h post-race (p < 0.01). No significant 218 
differences were observed in LDL and cholesterol levels between groups.  219 
DISCUSSION  220 
The purpose of this study was to analyze macro- and micro-nutrient intakes that are generally consid-221 
ered to be related to cardiovascular health in recreational marathon runners, and report the effect on 222 
racing time and on blood cardiac biomarkers. Regarding training, selected runners presented no dif-223 
ferences in their training years, but in the total hours/week of training, despite the fact that the values 224 
in G1 were higher without presenting significant differences, the increase in intensive training 225 
hours/week of this group was significantly higher compared to G2 (Table 1), also justifying better 226 
performance in the race. Runners from the slower group (G2) were physically heavier than the faster 227 
group (G1), which would require more effort to move their body during the marathon. This difference 228 
among the participants was initially considered to be due to differences in nutritional intake. 229 
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In this context, we have observed that nutrition varies among participants (Table 2), but those who 230 
consumed more unsaturated fatty acids and adequate mineral intakes, especially iron, potassium and 231 
magnesium, had faster finishing times and a healthier lipid blood profile (Table 4). Runners in G1 had 232 
higher iron intake and this might benefit hemoglobin levels, preserving aerobic performance [2,7]. 233 
In addition, the slower runners presented higher circulating amounts of cardiovascular-damage bi-234 
omarkers, such as high triglycerides and low HDL (Table 4) [18]. When analyzing three well-known 235 
cardiovascular biomarkers (Table 3), all increased post-race, most notably Hs-TnT in slower runners 236 
(G2), and can confer long-term increased risk in cardiovascular health or can be a cardiac sport-driven 237 
adaptation [19].  238 
Altogether, these observations indicate that the slower runners are performing a very demanding aer-239 
obic effort with a less optimal profile, regarding circulating cardiovascular biomarkers. In this context, 240 
their diet choices, especially regarding fat and mineral intakes, could be the most relevant factors re-241 
sponsible for this outcome, although training also plays a prominent role. 242 
Although the amount of fat taken by both groups was adequate for endurance training [20], the most 243 
significant difference between the G1 and G2 groups was the type of fat consumed. Different studies 244 
have assessed that the type of fat (saturated vs. unsaturated) could be a main contributing factor to 245 
increased adiposity and higher triglyceride and LDL levels in blood [21]. Table 4 depicts how G2 246 
presents significantly higher levels of triglycerides compared to G1. At the same time, consuming 247 
more saturated fats correlates with higher body weights and BMI, hindering the performance of G2 248 
runners through mechanisms that require further research [22,23]. In addition, HDL (an indicator of 249 
arterial protection) was significantly higher in G1 (Table 4), which can increase due to aerobic exercise 250 
and higher amounts of monounsaturated fats in diet [24]. Taken together, this could translate to better 251 
cardiovascular health status in G1 vs. G2 (Table 3).  252 
Analyzing diet questionnaires, faster runners (G1) consumed frequent servings of seeds and nuts, more 253 
servings of fruits and vegetables, and adequate servings of whole cereals. Coincidently, many of these 254 
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foods are sources of unsaturated fatty acids. In addition, G2 finishers presented low amounts of certain 255 
minerals in their diet, such as Fe2+, K+ and Mg2+. Interestingly, the previously mentioned foods provide 256 
adequate amounts of these micronutrients. Unsaturated fats, as well as K+ and Mg2+, play an instru-257 
mental role in cardiac function [25], possibly favoring a more adaptive response to exercise [26]. This 258 
observation emphasizes the importance of an adequate selection of foods when designing training di-259 
ets, not only for macronutrients, but for specific micronutrients as well. In this manner, the runners 260 
can perform the race in healthier cardiovascular conditions. 261 
When physical activity such as the marathon is performed, there are energy and macronutrient needs, 262 
especially carbohydrates and proteins, that must be satisfied to maintain body weight, replenish gly-263 
cogen stores and provide adequate proteins to build and repair tissue [7]. In addition, fat intake should 264 
be sufficient to also provide energy along with essential fatty acids and fat-soluble vitamins [27,28]. 265 
Regarding the runners participating in this study, there are some points mentioned that can be im-266 
proved. Dietary recommendations for endurance runners are 5-10 g of carbohydrates/kg of body 267 
weight [2,13], but the amount consumed by the participants in this study was lower, and this deficiency 268 
could be related to the lower amounts (25%) of kcal consumed in their diet. Protein intakes were in 269 
the recommended range, although slightly lower in G2. However, these deficiencies in particular mac-270 
ronutrients do not seem to have an influence in the cardiovascular health status, since G1 runners did 271 
not present noticeable levels of circulating cardiac biomarkers [19].  Nevertheless, a first corrective 272 
intervention in the population studied should focus on adding more carbohydrates for optimal perfor-273 
mance. 274 
A limitation of the study was the small group sample. Another limitation was to not know if a deficient 275 
intake in K+ and Mg2+ can lead to decreased performance of certain body compartments, such as the 276 
heart. The body content of the electrolytes studied (Table 4), particularly Mg2+, was unknown, as this 277 
requires specific overloading protocols that we have not performed [14,29,30]. In the present study, 278 
lower consumption of K+ and Mg2+ in the diet does not result in a hypokalemia or hypomagnesemia, 279 
as the circulating electrolyte content was very similar between both groups. Additional studies must 280 
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be carried out to answer this question. In addition, our future research direction is focused on proving 281 
if the above-mentioned diet changes in a population of recreational runners similar to G2 would im-282 
prove the circulating profile of cardiovascular health biomarkers.   283 
In conclusion, the consumption of mono- and poly-unsaturated fatty acids and a correct intake of K+ 284 
and Mg2+, in non-athlete (recreational) marathon runners, performed better (had shorter race times) 285 
without compromising their health status assessed by a correct circulating lipid profile (the present 286 
study) and no noticeable circulating cardiovascular risk biomarkers [19]. Nevertheless, the diet of rec-287 
reational runners needs to be improved in certain macronutrients and the relation to the health status 288 
must be assessed in future studies. 289 
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Table 1: Anthropometric and training data of the participants in the study.  384 
Parameters Total 
Fast runner group 
(G1) 
Slow runner group (G2) 
Age (years) 38.06 ± 6.31  37.50 ± 6.13  38.65 ± 6.62  
Weight (kg) 77.08 ± 7.59 74.70 ± 7.76  79.58 ± 6.72*a 
Height (cm) 178.70 ± 5.72  180.11 ± 6.10  177.22 ± 5.02  
BMI (kg/m2) 24.12 ± 2.22  23.01 ± 1.81  25.30 ± 2.02**a 
% Weight lost 3.08 ± 1.63  3.50 ± 1.88  2.63 ± 1.52  






very intensive  
6.93 ± 3.01  
 
1.92 ± 1.37 
2.63 ± 1.41 
1.87 ± 0.98 
0.95 ± 0.63 
7.63 ± 3.00  
 
2.24 ± 1.44 
2.92 ± 1.68 
2.03 ± 0.85 
0.87 ± 0.52 
6.19 ± 2.93  
 
1.59 ± 1.25 
2.32 ± 1.01 
1.71 ± 1.10 
1.03 ± 0.72 
Race time (h) 3.50 ± 0.46  3.18 ± 0.18  3.84 ± 0.42**b 
 385 
Values presented as mean ± SD.  386 
*p < 0.05; **p < 0.01 significant differences when comparing both groups. 387 
Statistical analysis: aOne-way Anova, bKruskal-Wallis. 388 
Abbreviations used: BMI, body mass index; h, hours. 389 
  390 
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Table 2: Nutrition intake of the participants in the study.  391 









































































Cholesterol (mg) 246.64 (99.16-882.17) 273.46 (141.12-882.17) 197.78 (99.16-381.55) 
Dietary fiber (g/day) 25.17 (12.49-50.95) 31.39 (22.93-50.95) 21.35 (12.49-40.99)** 
Water (ml) 1096.81 (426.14-1957.36) 1189.79 (590.03-1957.36) 967.14 (426.14-1752.57) 
Na (mg/day) 2243.13 (1641.16-3537.06) 2215.13 (1718.26-3537.06) 2269.58 (1641.16-3449.99) 
K (mg/day) 3035.68 (1530.55-6246.98) 3367.56 (2257.26-6246.98) 2413.64 (1530.55-4936.00)** 
Fe (mg/day) 16.80 (9.45-32.44) 20.16 (11.07-25.30) 12.65 (9.45-32.44)* 
Ca (mg/day) 709.02 (263.27-1531.08) 709.51 (504.24-1531.08) 682.92 (263.27-1138.44) 




Values presented as median (IQR).  395 
*p < 0.05; **p < 0.01 significant differences when comparing both groups. 396 
Statistical analysis: Kruskal-Wallis.  397 
Abbreviations used: Na, sodium; K, potassium; Fe, iron; Ca, calcium; Mg, magnesium. 398 
 399 
  400 
 
19 
Table 3: Circulating blood biomarkers of muscle damage, inflammation and cardiovascular 401 
health of the participants in the study. 402 



























































































Values presented as median (IQR).  404 
*p < 0.05; **p < 0.01 significant differences when comparing both groups. 405 
Statistical analysis: Kruskal-Wallis.  406 
Abbreviations used: CK, creatine kinase; CRP, C-reactive protein; Hs-TnT, high-sensitive troponin-T; NT-proBNP, N-terminal pro-B-type natriu-407 
retic peptide.  408 
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Table 4: Circulating blood electrolytes and lipid profile of the participants in the study.  409 






139.95 ± 1.75  
142.73 ± 2.74  
141.62± 1.83  
 
140.00 ± 1.92  
143.47 ± 2.78  
141.37 ± 2.14  
 
139.89 ± 1.61  
141.94 ± 2.53  






4.12 ± 0.33  
4.2 ± 0.38  
4.17± 0.24  
 
4.18 ± 0.32  
4.30 ± 0.29  
4.13 ± 0.27  
 
4.05 ± 0.33  
4.23 ± 0.46  






2.07 ± 0.13  
1.76 ± 0.18  
2.17± 0.13  
 
2.05 ± 0.11  
1.73 ± 0.15  
2.20 ± 0.13  
 
2.08 ± 0.14  
1.80 ± 0.21  






117.57 ± 69.09  
99.08 ± 20.12  
120.57 ± 66.16  
 
87.95 ± 39.95  
101.47 ± 25.18  
89.68  ± 40.02  
 
148.83 ± 80.02 *b 
96.56 ± 13.16  






99.60 ± 24.69  
96.46 ± 20.75  
92.19 ± 22.76  
 
97.53 ± 23.88  
91.90 ± 21.12  
93.68  ± 22.78  
 
101.28 ± 26.03  
101.28 ± 19.78  






60.57± 12.50  
59.16 ± 11.36  
60.30 ± 12.66  
 
66.32 ± 9.60  
63.79 ± 10.39  
66.79 ± 11.22  
 
54.50 ± 12.54 **a 
54.28 ± 10.48 **b 








183.68 ± 24.45  
175.41 ± 21.02  
176.70 ± 24.17  
 
181.37 ± 21.96  
176.00 ± 21.73  
178.47 ± 25.30  
 
186.11 ± 27.26  
174.78 ± 20.84  
174.83 ± 23.51  
 410 
Values presented as mean ± SD.  411 
*p < 0.05; **p < 0.01 significant differences when comparing both groups. 412 
Statistical analysis: aOne-way Anova, bKruskal-Wallis.  413 
Abbreviations used: Na, sodium; K, potassium; Mg, magnesium; LDL, low-density lipoprotein; HDL, high-density lipoprotein. 414 
